NCT02511990View on ClinicalTrials.gov

A Study of the Safety, Pharmacokinetics and Antiretroviral Activity of 10-1074

PHASE1CompletedINTERVENTIONAL
Enrollment

33

Participants

Timeline

Start Date

July 31, 2015

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2017

Conditions
HealthyHIV
Interventions
BIOLOGICAL

3 mg/kg, single dose IV administration of 10-1074

3 mg/kg, single dose IV administration of 10-1074

BIOLOGICAL

10 mg/kg, single dose IV administration of 10-1074

10 mg/kg, single dose IV administration of 10-1074

BIOLOGICAL

30 mg/kg, single dose IV administration of 10-1074

30 mg/kg, single dose IV administration of 10-1074

Trial Locations (2)

10065

The Rockefeller University, New York

50937

University of Cologne, Cologne

All Listed Sponsors
collaborator

University of Cologne

OTHER

lead

Rockefeller University

OTHER

NCT02511990 - A Study of the Safety, Pharmacokinetics and Antiretroviral Activity of 10-1074 | Biotech Hunter | Biotech Hunter